🧪 Learn how these findings can improve the ability to study disease linked to poor outcomes and provide new patient-derived models to help evaluate potential treatment strategies: bit.ly/4hDnGIM
@stjuderesearch.bsky.socialSt. Jude Children's Research Hospital
@stjuderesearch.bsky.social
Driving discoveries and innovative treatments for childhood cancer and other diseases. Ranked #3 by USNWR. #StJude #StJudeResearch
@stjuderesearch.bsky.social@stjuderesearch.bsky.socialSt. Jude scientists and collaborators built a comprehensive dataset of neuroblastoma samples, incorporating multiple leading-edge technologies, to identify a gene expression signature that distinguishes high-risk, treatment-resistant neuroblastoma cells from lower-risk cells.
@stjuderesearch.bsky.socialLooking to expand your perspective on pediatric cancer research? Hear why postdoctoral research associate Tuyu Zheng, PhD, recommends The Science of Childhood Cancer virtual lecture series for trainees and early-career researchers.
Join upcoming lectures through Nov. 19: bit.ly/3TD4Rvy
@stjuderesearch.bsky.socialAmong those sharing advances in pediatric cancer in plenary sessions were Noha Shendy, PhD; Mark Hatley, MD, PhD; and Alejandro Gutierrez, MD. Shendy, Grace McKay-Corkum, MD, and Mohammad Ali Mohammad Nezhady, PhD, also presented abstracts.
@stjuderesearch.bsky.socialSt. Jude researchers attended the @theaacr.bsky.social Special Conference in Cancer Research which focused on bridging discovery and clinical impact in pediatric cancer. @cmullighan.bsky.social gave the keynote address on working toward a cure for acute leukemia through the lens of genomics.
@stjuderesearch.bsky.socialAcross St. Jude, postdoctoral researchers spend countless hours conducting experiments, analyzing data and advancing the research that powers our mission.
As #NPAW comes to a close, we celebrate the impact of our postdocs who help make world-class science possible at St. Jude.
@stjuderesearch.bsky.socialProud to be ranked No. 1 on @forbes.com' 2026 list of America's Best Employers for Healthcare Professionals.
We're committed to supporting the people who advance the St. Jude mission every day, from patient care and research to the many roles that make our work possible.
@stjuderesearch.bsky.socialKDM2B is a potential therapeutic target in Group 3 and Group 4 medulloblastoma. Researchers found that removing the gene or degrading the protein slowed tumor growth and prolonged survival in preclinical models, offering a strategy for high-risk tumors that lack targeted therapies. 🧪 bit.ly/4jnzC2h
@stjuderesearch.bsky.socialBy aligning country leadership, lived experience and proven interventions, OneSCD aims to accelerate progress toward more equitable diagnosis, treatment and care for children and families affected by sickle cell disease.
@stjuderesearch.bsky.socialAt the United Nations General Assembly, St. Jude Children's Research Hospital joined global partners, including @who.int, @unicef.org, Africa CDC and the World Coalition on Sickle Cell Disease to launch OneSCD, a new initiative that will strengthen and connect sickle cell disease efforts worldwide.
@stjuderesearch.bsky.socialSt. Jude scientists identified ZMYND8 as a major regulator of CD8+ T-cell exhaustion. Targeting the gene improved immune function and enhanced immunotherapy, offering a potential new strategy to strengthen anti-tumor responses in solid tumors. 🧪 https://bit.ly/3TiiMrc
@stjuderesearch.bsky.socialDuring Postdoc Appreciation Week, St. Jude faculty are sharing messages of gratitude for the postdocs whose talent, dedication and discoveries help advance our mission.
Thank you to all our postdocs!
@stjuderesearch.bsky.socialCongratulations to Duffy on receiving both the Young SIOP Leadership Assembly Award and the Young Investigator Award!
@stjuderesearch.bsky.socialAt #SIOP2026, Caitlyn Duffy, MD, MPH, shared how the ARIA Guide is helping expand access to evidence-based childhood cancer care worldwide.
Developed through worldwide collaboration, ARIA provides resource-stratified clinical guidance designed for a wide range of care settings. Learn more:
@stjuderesearch.bsky.socialSt. Jude survivorship research was also presented as part of a late-breaking session at SIOP 2026. Together, the work advances understanding of survivor-specific risks and helps inform strategies that may improve long-term health and quality of life for childhood cancer survivors.
@stjuderesearch.bsky.socialSt. Jude researchers shared work on physical activity interventions, cardiovascular risk after platinum chemotherapy, genetic factors linked to long-term health outcomes, and the connections between sleep health, psychological distress and social determinants.
@stjuderesearch.bsky.socialSurvivorship research featured at #SIOPcongress explored how to improve life after childhood cancer.
@stjuderesearch.bsky.socialCongratulations to Michael McNeil, MD, MPH, director of the St. Jude Global Palliative Care Program, who received the 2026 SIOP North America Rising Star Award for advancing culturally relevant, sustainable approaches to pediatric palliative care through global collaboration.
@stjuderesearch.bsky.social“Experience matters when thinking about a good outcome. It’s not just the surgeon, it’s the whole team,” Davidoff said. #SIOPcongress #SIOP2026
@stjuderesearch.bsky.socialDrawing on 147 patients with bilateral Wilms tumor treated at St. Jude, where 87% kept parts of both kidneys, he highlighted advances in surgical technique, imaging and multidisciplinary care.